September 29, 2026
Breaking
Business

Gujarat Themis secures $58 million private credit for Japanese acquisition

admin1 min read

Founded in 1981, Gujarat Themis is India’s first company to start commercial production of the anti-tuberculosis drug Rifampicin, according to its website

The post Gujarat Themis secures $58 million private credit for Japanese acquisition appeared first on Home Page.

Leave a Comment

Your email address will not be published. Required fields are marked *